The Derma Co 1% Hyaluronic Sunscreen Oil-Free Gel Clinical Testing
TDC 1% Hyaluronic Sunscreen Oil-Free Matte Gel: Efficacy and Clinical Testing Guide
CCFT Laboratories sunscreen efficacy certificate CCFT2329 reports in-vivo UVA-PF 44.56 (PPD 44), PA++++, in-vitro SPF 186.33, in-vitro UVA-PF 59.16 and a critical wavelength of 379 nm.
This product was evaluated for sunscreen efficacy at CCFT Laboratories Pvt. Ltd. in accordance with international standards and regulatory guidelines.
At a Glance: Sunscreen Efficacy Metrics
| In-Vivo UVA-PF / PPD | In-Vitro SPF | PA Rating | Broad Spectrum | Critical Wavelength |
|---|---|---|---|---|
| 44.56 (PPD 44) | 186.33 | PA++++ | Yes | 379 nm |
1. Study Overview and Design Parameters
| Study Parameter | Detail |
|---|---|
| Study Title | Sunscreen Efficacy Study — The Derma Co. 1% Hyaluronic Sunscreen Oil Free Matte Gel |
| Specific Parameters Measured | In-vivo UVA-PF and PPD, in-vitro SPF and UVA-PF, PA Rating, Critical Wavelength, Broad Spectrum Classification and Boots Star Rating |
| Why These Parameters Matter | UVB radiation causes sunburn and contributes to skin cancer. UVA radiation penetrates deeper to cause photoaging, tanning, and long-term structural skin damage. The PA rating system communicates UVA protection levels. Critical wavelength confirms the breadth of spectral coverage. |
| Study Type | In-vivo and in-vitro sunscreen efficacy evaluation |
| Testing Methods | IS 17492:2021 (ISO 24442:2022) for in-vivo UVA-PF; ISO 24443:2021 or IS 17493:2021 for in-vitro testing |
| Specific Product Studied | The Derma Co. 1% Hyaluronic Sunscreen Oil Free Matte Gel (as named on certificate CCFT2329) |
| Product Connection | The CCFT2329 certificate reports in-vitro SPF 186.33, in-vivo UVA-PF 44.56 (PPD 44), and PA++++. The certificate does not report an in-vivo SPF result. The formulation description on this page also identifies Sodium Hyaluronate, Niacinamide, and the Aquaxyl complex; those ingredient details are not independently verified by CCFT2329. |
2. Claim Substantiation Matrix
| Claim | Certificate | Evidence | Status |
|---|---|---|---|
| In-Vitro SPF 186.33 | Sunscreen Efficacy Certificate | In-vitro SPF 186.33 reported under ISO 24443:2021 or IS 17493:2021; not an in-vivo SPF measurement | Supported |
| PA++++ | Sunscreen Efficacy Certificate | PA++++ rating reported in the sunscreen efficacy certificate | Supported |
| Broad Spectrum | Sunscreen Efficacy Certificate | Critical Wavelength 379 nm exceeds the 370 nm threshold | Supported |
| In-Vivo UVA-PF Tested | Sunscreen Efficacy Certificate | In-vivo UVA-PF 44.56 (PPD 44) using IS 17492:2021 (ISO 24442:2022) | Supported |
| Certificate Report | CCFT Laboratories | Report No. CCFT2329, issued by CCFT Laboratories; this certificate does not list a CTRI registration | Verified |
3. Sunscreen Efficacy Study Details
3.1 Lab, Date, Standards, and Registration
| Field | Detail |
|---|---|
| Product Tested | The Derma Co. 1% Hyaluronic Sunscreen Oil Free Matte Gel |
| Sponsor / Brand Owner | The Derma Co (Honasa Consumer Ltd) |
| Testing Laboratory | CCFT Laboratories Pvt. Ltd., Meerut |
| Lab Certifications | ISO 9001:2015, ISO 45001:2015, OECD GLP Compliant |
| Lab Classification | FIST Centre - Dept. of Science & Technology, Govt. of India |
| Certificate Report No. | CCFT2329 |
| Sponsor | Honasa Consumer Ltd. |
| In-Vivo UVA-PF Test Method | IS 17492:2021 (ISO 24442:2022) |
| In-Vivo UVA-PF / PPD Result | 44.56 (PPD 44) |
| In-Vitro Test Method | ISO 24443:2021 or IS 17493:2021 |
| In-Vitro SPF Result | 186.33 |
| In-Vitro UVA-PF Result | 59.16 |
| PA Rating | PA++++ |
| Broad Spectrum | Yes |
| Critical Wavelength | 379 nm |
| Signed By | Puneet Mittal, Director R&D, CCFT Laboratories |
Original Sunscreen Efficacy Certificate
Certificate CCFT2329 reports in-vivo UVA-PF 44.56 (PPD 44), in-vitro SPF 186.33, in-vitro UVA-PF 59.16, PA++++, Broad Spectrum: Yes, critical wavelength 379 nm, and Boots Star Rating: ***.
3.2 Test Results and Clinical Interpretation
| Metric | Result | Clinical Interpretation |
|---|---|---|
| UVA-PF (In-Vivo) | 44.56 (PPD 44) | Reported using IS 17492:2021 (ISO 24442:2022); supports the PA++++ UVA protection classification. |
| SPF (In-Vitro) | 186.33 | In-vitro SPF reported in CCFT2329 under ISO 24443:2021 or IS 17493:2021. The certificate does not report an in-vivo SPF. |
| UVA-PF (In-Vitro) | 59.16 | In-vitro UVA protection factor reported in the CCFT2329 certificate. |
| PA Rating | PA++++ | PA++++ is the highest category in the Protection Grade of UVA system used in Asia. It signifies maximum defense against long-wave UVA rays that cause deep structural photoaging. |
| Critical Wavelength | 379 nm | Critical wavelength measures the point where 90% of a sunscreen's total UV absorbance occurs. At 379 nm, the product exceeds the 370 nm international threshold, confirming extended coverage into the UVA-I range. |
3.3 80-Minute Water-Resistance Study
A separate in-vitro water-resistance study evaluated the product after a defined 80-minute water-exposure procedure. The reported water-resistant capacity was 50.34%. Because the result was above the report's 50% qualification threshold, the tested sample qualified as water-resistant for 80 minutes.
| Field | Verified Detail |
|---|---|
| Study | In-Vitro Estimation of Water-Resistant Capacity of 1% Hyaluronic Sunscreen Oil-Free Gel |
| Project No. | CCFT-2025-07-1493H |
| Report No. | MIET/CCFT/2025-07/1493H/WRR |
| Water-Resistant Capacity at 80 min | 50.34% |
| Conclusion | Qualified as water-resistant for 80 minutes under the stated in-vitro test conditions |
Original 80-Minute Water-Resistance Report
Project No. CCFT-2025-07-1493H | Report No. MIET/CCFT/2025-07/1493H/WRR. The tested sample recorded 50.34% water-resistant capacity at 80 minutes.
3.4 Photostability Study
A separate photostability study assessed the sunscreen under natural-light and artificial-irradiation conditions. The report's acceptance criterion required an AUC ratio and UVAPF retention ratio of at least 0.8, together with broad-spectrum status. The tested sample achieved AUCfinal/AUCinitial = 0.96 and UVAPFfinal/UVAPFinitial = 0.97, and the report concluded that the sample was photostable.
| Photostability Metric | Initial | 6 Hours / Post-Irradiation | Verified Result |
|---|---|---|---|
| Natural Light SPF Mean | 56.74 | 45.98 | AUC retention ratio 0.96 |
| Natural Light UVAPF Mean | 13.57 | 12.94 | Critical wavelength remained 373 nm |
| Artificial Irradiation | Pre-irradiation UVAPF 13.87 | Post-irradiation UVAPF 13.44 | UVAPF retention ratio 0.97 |
| Conclusion | Broad spectrum under the study conditions | Photostable | |
Original Photostability Study Report
Project No. CCFT-2025-03-H1074 | Report No. MIET/CCFT/2025-03/H1074Photostability. The report confirms photostability based on AUC retention 0.96 and UVAPF retention 0.97.
4. Formulation Architecture and UV Filter System
The sunscreen formulation is described below; certificate CCFT2329 identifies the test product as The Derma Co. 1% Hyaluronic Sunscreen Oil Free Matte Gel. The formulation uses a multi-filter system designed for broad-spectrum coverage, photostability, and skin compatibility.
| Formulation System | Key Components | Function and Performance Rationale |
|---|---|---|
| UVB Filter System | Ethylhexyl Methoxycinnamate, Phenylbenzimidazole Sulfonic Acid, Ethylhexyl Salicylate | These three UVB filters absorb radiation in the 290-320 nm range to contribute to the sunscreen's UVB protection. Ethylhexyl Salicylate additionally functions as an Avobenzone photostabilizer. |
| UVA Filter System | Butyl Methoxydibenzoylmethane (Avobenzone), Terephthalylidene Dicamphor Sulfonic Acid (Mexoryl SX) | Avobenzone absorbs radiation primarily at the 360 nm range. Mexoryl SX extends coverage across the broader UVA spectrum. Together, they drive the PA++++ UVA protection and the 379 nm critical wavelength. |
| Broad Spectrum Anchor | Methylene Bis-Benzotriazolyl Tetramethylbutylphenol (Tinosorb M) | Tinosorb M absorbs and scatters UV radiation across both UVA and UVB ranges. It anchors the overall protective range to achieve the broad spectrum classification. |
| Photostabilization System | Ethylhexyl Salicylate, Tinosorb M | Avobenzone degrades rapidly under direct UV exposure when used alone. This formula includes Ethylhexyl Salicylate and Tinosorb M to prevent this degradation. These stabilizers ensure the UV filters maintain their protective performance under continuous sun exposure. |
| Hydration System | Sodium Hyaluronate, Glycerin, Propylene Glycol, Aquaxyl Complex | The hydration system uses Sodium Hyaluronate as the primary humectant. The Aquaxyl complex draws moisture into multiple layers of the stratum corneum. This combination prevents transepidermal water loss during daily wear. |
| Skin Health Actives | Niacinamide, Tocopheryl Acetate, Blueberry Extract, Allantoin, Biosaccharide Gum-4 | Niacinamide supports the skin barrier and reduces hyperpigmentation. Vitamin E and Blueberry Extract provide antioxidant protection against free radicals. Allantoin conditions the skin, while Biosaccharide Gum-4 supports the cutaneous microbiome. |
| Texture and Distribution | Ammonium Acryloyldimethyltaurate/VP Copolymer, Isododecane, Tapioca Starch, Olivem 1000 | The gel matrix ensures uniform UV filter distribution across the skin surface. Isododecane aids rapid spreading before evaporating. Tapioca Starch absorbs sebum to provide a matte finish. Uniform distribution prevents gaps in UV protection. |
4.1 Exclusion Profile: What is Not in This Formula
| What is absent | Why it matters |
|---|---|
| No mineral oil | The formula uses lightweight emollients like Caprylic/Capric Triglyceride instead of petrolatum derivatives. This supports the oil-free claim and prevents a greasy finish. |
| No heavy occlusives | The gel formulation avoids heavy waxes and butters. This prevents a greasy feel and supports comfortable daily wear. |
| No physical UV filters | This chemical sunscreen uses organic UV filters instead of mineral filters like zinc oxide. Organic filters provide a transparent finish without the white cast associated with mineral sunscreens. |
5. Published Research on Key UV Filters and Actives
| Ingredient | Primary Published Finding | Relevance to Product |
|---|---|---|
| Avobenzone | Avobenzone absorbs UVA radiation at 360 nm but degrades rapidly when unprotected. Research shows that photostabilizers like Octisalate and Tinosorb M prevent this degradation and maintain UVA protection. | Primary UVA filter; photostabilized by Octisalate and Tinosorb M in this formula. |
| Tinosorb M | Tinosorb M provides dual UVA and UVB protection through absorption and scattering. Research demonstrates it is highly photostable and functions as an effective Avobenzone photostabilizer. | Broad-spectrum anchor; contributes to broad-spectrum protection; CCFT2329 reports in-vitro SPF 186.33, PA++++, and a 379 nm critical wavelength. |
| Mexoryl SX | Clinical studies confirm Mexoryl SX provides UVA protection across the 310-400 nm range. It is inherently photostable and complements Avobenzone for comprehensive coverage. | Extends UVA coverage; contributes to PA++++ rating and broad spectrum classification. |
| Niacinamide | A 2002 randomized clinical trial found that 5% niacinamide significantly reduced hyperpigmented spot area after 8 weeks. A 2004 study demonstrated that niacinamide improves skin barrier function and reduces transepidermal water loss. | Supports skin barrier and reduces hyperpigmentation in daily-use sunscreen. |
| Sodium Hyaluronate | Hyaluronic acid is a humectant that draws moisture to the stratum corneum. Clinical studies demonstrate its ability to improve skin hydration and reduce transepidermal water loss. | Provides hydration support in daily-use sunscreen, preventing dryness. |
6. Frequently Asked Questions About Sunscreen Efficacy
A: CCFT2329 reports in-vitro SPF 186.33 under ISO 24443:2021 or IS 17493:2021. This is a laboratory in-vitro measurement, not an in-vivo SPF result or the product's consumer-labelled SPF.
A: The supplied sunscreen efficacy certificate reports a PA++++ rating for the tested product. It also reports in-vivo UVA-PF 44.56 (PPD 44) and in-vitro UVA-PF 59.16.
A: PA++++ is the highest classification in the Protection Grade of UVA system used in Asia, corresponding to an in-vivo UVA-PF of at least 16. It signifies maximum defense against long-wave UVA rays that cause deep structural photoaging and tanning.
A: In-vivo testing measures protection on human skin; CCFT2329 reports in-vivo UVA-PF 44.56 (PPD 44) under IS 17492:2021 (ISO 24442:2022). In-vitro laboratory methods reported SPF 186.33 and UVA-PF 59.16. The new certificate does not state an in-vivo SPF result.
A: Broad Spectrum is a regulated classification confirming that a sunscreen provides verified protection across both UVB and UVA wavelengths. A product must achieve a critical wavelength of at least 370 nm to earn this designation.
A: Critical wavelength measures the point where 90% of a sunscreen's total UV absorbance occurs. At 379 nm, this product exceeds the 370 nm international threshold, confirming extended coverage into the UVA-I range responsible for deep skin penetration.
A: CCFT Laboratories issued sunscreen efficacy certificate CCFT2329 for The Derma Co. 1% Hyaluronic Sunscreen Oil Free Matte Gel. It reports in-vivo UVA-PF 44.56 (PPD 44), in-vitro SPF 186.33 and UVA-PF 59.16. This certificate does not list a CTRI registration.
A: CCFT Laboratories is a Department of Science and Technology designated FIST Centre that operates under OECD Good Laboratory Practice guidelines. The facility holds ISO 9001:2015 and ISO 45001:2015 certifications for quality and occupational health management.
A: Yes, the TDC 1% Hyaluronic Sunscreen Oil-Free Gel tested at CCFT Laboratories is the exact commercial formulation sold to consumers. No modifications or prototype variations were used during the efficacy evaluation.
A: Synthetic organic filters like Avobenzone and Tinosorb M are required to absorb and scatter UV radiation to achieve high SPF and PA ratings. Natural extracts like Hyaluronic Acid and Blueberry Extract are included separately to provide topical hydration and antioxidant support.
7. Lab References and Certificate Details
| Field | Detail |
|---|---|
| Testing Laboratory | CCFT Laboratories Pvt. Ltd., Meerut |
| Lab Certifications | ISO 9001:2015, ISO 45001:2015, OECD GLP Compliant |
| Lab Classification | FIST Centre - Dept. of Science & Technology, Govt. of India |
| Certificate Report No. | CCFT2329 |
| Sponsor | Honasa Consumer Ltd. |
| In-Vivo UVA-PF Test Method | IS 17492:2021 (ISO 24442:2022) |
| In-Vitro Test Method | ISO 24443:2021 or IS 17493:2021 |
| Sponsor / Brand Owner | The Derma Co (Honasa Consumer Ltd) |
| Signed By | Puneet Mittal, Director R&D, CCFT Laboratories |
| Certificate Date | Not specified in CCFT2329 |
| Sunscreen Efficacy Certificate | View Certificate PDF |
| 80-Min Water-Resistance Report | View WRR PDF |
| Photostability Study Report | View Photostability PDF |
All certificates on this page reflect testing on the product formulation as commercially available. Results are test-specific. Real-world outcomes may differ from study conditions. Reapplication as directed on product packaging is recommended regardless of photostability.
8. References
- Hakozaki T, et al. The effect of niacinamide on reducing cutaneous pigmentation and suppression of melanosome transfer. Br J Dermatol. 2002;147(1):20-31. PMID: 12100180.
- Bissett DL, et al. Topical niacinamide reduces yellowing, wrinkling, red blotchiness, and hyperpigmented spots in aging facial skin. Int J Cosmet Sci. 2004;26(5):231-8. PMID: 18492135.
- National Institutes of Health, Office of Dietary Supplements. Niacinamide Fact Sheet for Health Professionals. NIH; 2021.
- ISO 24442:2022 / IS 17492:2021. In-vivo determination of UVA protection factor, as cited in CCFT2329.
- ISO 24443:2021 / IS 17493:2021. In-vitro sunscreen test methods cited in CCFT2329.
- Diffey BL. The CIE action spectrum for ultraviolet-induced erythema and its use in determining the sun protection factor of sunscreen agents. J Photodermatol Photoimmunol Photomed. 1991;8(4):160-2.
- Wang SQ, et al. Photoprotection: A review of the current and future technologies. Dermatol Ther. 2010;23(1):31-47. PMID: 20136889.
- CCFT Laboratories Pvt. Ltd. Sunscreen Efficacy Certificate for The Derma Co. 1% Hyaluronic Sunscreen Oil Free Matte Gel. Report No. CCFT2329. View Certificate
- Centre for Cruelty-Free Testing, MIET Meerut. In-Vitro Estimation of Water-Resistant Capacity of 1% Hyaluronic Sunscreen Oil-Free Gel. Project No. CCFT-2025-07-1493H; Report No. MIET/CCFT/2025-07/1493H/WRR. View Report
- Centre for Cruelty-Free Testing, MIET Meerut. Photostability of TDC 1% Hyaluronic Sunscreen Oil-Free Gel. Project No. CCFT-2025-03-H1074; Report No. MIET/CCFT/2025-03/H1074Photostability. View Report
Annexure: Water Resistance & Photostability Evidence
| Evidence Type | Verified Finding |
|---|---|
| 80-Minute Water Resistance | Water-resistant capacity measured at 50.34%; the report states that the sample qualifies as water-resistant for 80 minutes. |
| Photostability – Natural Light | AUCfinal/AUCinitial = 0.96 after the reported exposure sequence; critical wavelength remained 373 nm through 6 hours. |
| Photostability – Artificial Irradiation | UVAPFfinal/UVAPFinitial = 0.97; the report concludes the tested sample is photostable and broad spectrum. |
| Important Usage Note | Water resistance and photostability are test-specific properties. They do not remove the need to follow the product's application and reapplication directions. |
80-Minute Water-Resistance Report
Project No. CCFT-2025-07-1493H | Water-resistant capacity: 50.34%.
Photostability Report
Project No. CCFT-2025-03-H1074 | AUC retention: 0.96 | UVAPF retention: 0.97.
